Technology Industry
Industry: Email Alert RSS FeedLantibio of Chapel Hill and Apotex Fermentation of Winnipeg, Canada, have signed an agreement for the development and supply of Lantibio's lead compound
BT Catalyst, Sept-Oct, 2005
Lantibio of Chapel Hill and Apotex Fermentation of Winnipeg, Canada, have signed an agreement for the development and supply of Lantibio's lead compound, Moli1901, being tested for the treatment of dry eye syndrome and cystic fibrosis.
- Most Popular Articles in Technology
- An overview of continuous data protection
- Why all those current ratings?
- Many countries now have a mobile penetration rate above 100%, report says
- The Tata Group's big telecom gamble: VSNL's recent acquisition of Tyco ...
- MEASURING BANK BRANCH EFFICIENCY USING DATA ENVELOPMENT ANALYSIS: MANAGERIAL ...
- More »
COPYRIGHT 2005 North Carolina Biotechnology Center
COPYRIGHT 2008 Gale, Cengage Learning